저자의 연구 키워드

저자의 연구 키워드

#177Lu-DOTATATE

#Adenosine deaminase

#Adjuvant chemoradiotherapy

#Administration

#Albumin-bound paclitaxel

#Antineoplastic agents

#Aromatase inhibitors

#Awareness

#Benign

#Biliary tract neoplasms

#Blood platelets

#Breast neoplasms

#CA 19-9 antigen

#Carcinoembryonic antigen

#Chemoradiotherapy

#Circulating tumor DNA

#Cisplatin

#CKD-516

#Clinical trial

#Colorectal neoplams

#Colorectal neoplasms

#ctDNA

#Diabetes mellitus

#DNA methylation

#drug resistance

#Drug therapy

#Epigenomics

#ErbB receptors

#Exemestane

#First-line treatment

#FOLFIRI

#GC1118

#Gemcitabine

#Genetic polymorphism

#GLI family zinc finger 1

#Gonadotropin-releasing hormone

#HER2-positive gastric cancer

#High-throughput nucleotide sequencing

#Histone modification

#Hormone receptor-positive

#Interleukin-1beta

#Irinotecan

#Korea

#KX-01

#lapatinib

#Letrozole

#Leukocytes

#Liquid biopsy

#LPHN2

#Mediastinal lymph node

#Metastatic breast cancer

#Metformin

#Microtubules

#Minimal residual disease

#Mitotic catastrophe

#Molecular profiling

#Monoclonal antibody

#Mutation

#Neoadjuvant therapy

#Neoplasm metastasis

#Neoplasms

#Neuroendocrine tumors

#No-carrier added

#Nomograms

#Non-small cell lung carcinoma

#Obesity

#OPB-31121

#Oral

#Ovariectomy

#Oxaliplatin

#Paclitaxel

#Pancreatectomy

#Pancreatic neoplasms

#Patients

#Peptide receptor radionuclide therapy

#Perception

#P-glycoprotein

#Pharmacokinetics

#Phase 1

#Phase I

#Phase I clinical trial

#Phase II trial

#phosphoproteins

#Premenopause

#Prognosis

#Pulmonary nodule

#Q-Exactive

#Regorafenib

#RNA editing

#S-1

#Segmental mastectomy

#Sinusoidal obstruction syndrome

#SNU-KB-01

#Solid tumor

#Splenic artery

#Splenomegaly

#Src kinase inhibitor

#STAT3

#STAT3 inhibitor

#therapeutic targets

#Transcriptome sequencing

#Transforming growth factor beta1

#Triple negative breast neoplasms

#Tumor biomarker

#Vascular disrupting agent

#Vascular endothelial growth factor

#Volition